The Foundation to Combat Antimicrobial Resistance
Dr. Pickett recently retires as President, Research and Development at Biogen Idec, Inc. Prior to joining Biogen Idec (2006 – 2009), Dr. Pickett held several senior R&D positions, including Corporate Senior Vice President of Schering-Plough Corp. and President of Schering-Plough Research Institute. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co.
Dr. Pickett received his B.Sc. in biology from California State University at Hayward and his Ph.D. in cell biology from University of California at Los Angeles. He is a member of the Institute of Medicine of The National Academy of Sciences. Dr. Pickett previously served as a director of Biogen Idec. Board Committees: Compensation and Management Development Committee, Corporate Governance Committee and Science and Technology Committee (Chair).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
The Foundation to Combat Antimicrobial Resistance
The Foundation to Combat Antimicrobial Resistance isa drug development company and develop drugs to fight antimicrobial resistant organisms.